HK joins global drug regulatory body ICH

Hong Kong has officially end up being a regulative member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), a relocation the Health Bureau states marks an essential action towards developing the city into a global health care development center.

The ICH confessed Hong Kong, represented by the Pharmacy and Poisons Board, as its 20th regulative member at its assembly in the Czech Republic on Tuesday.

Other regulative members consist of the National Medical Products Administration of China, along with regulators from Europe, Switzerland, the UK and the United States.

The ICH is an essential global platform for collaborating technical requirements on drug guideline, setting standards covering security, effectiveness and quality.

Secretary for Health Lo Chung-mau stated the federal government regards thanked the nation for its assistance for Hong Kong’s advancement as a worldwide health care development center, stating the subscription totally shows the special benefits of “one country, two systems”

He kept in mind that Hong Kong ended up being an ICH observer on October 31, 2023, and had actually satisfied all of the body’s requirements in simply 3 years, far faster than the 8 to 10 years approximated previously.

Lo stated the federal government will establish a centre for medical items guideline to construct independent drug examination and approval capability to support medical research study on biopharmaceuticals.

“The HKSAR Government will establish the Centre for Medical Products Regulation (CMPR) next month to build up capacity for independent drug evaluation and approval, and actively participate in international co-operation, with a view to developing Hong Kong into an international health and medical innovation hub and better integrating into and serving the overall national development,” he stated.

Director of Health Ronald Lam stated signing up with the ICH is a huge advance.

“This is actually an important milestone in the development of drug and medical device regulation in Hong Kong, and it also marks the most critical step forward in establishing an internationally recognised, independent drug evaluation authority,” Lam stated.

Lam stated the soon-to-be-established centre will develop an expert group in accordance with ICH technical requirements, send out professionals to participate in preparing and modifying ICH standards, and aim to end up being a worldwide reliable regulator.

Modified by Cecil Wong


Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND

Subscribe to get the latest posts sent to your email.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Captcha verification failed!
CAPTCHA user score failed. Please contact us!

spot_imgspot_imgspot_imgspot_img